Gene: INTS6L
Official Full Name: integrator complex subunit 6 likeprovided by HGNC
Gene Summary: Predicted to be involved in snRNA 3'-end processing. Predicted to be part of integrator complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35865 | INTS6L Knockout cell line (HeLa) | Human | INTS6L | 1:3~1:6 | Negative | Online Inquiry |
KO35866 | INTS6L Knockout cell line (HCT 116) | Human | INTS6L | 1:2~1:4 | Negative | Online Inquiry |
KO35867 | INTS6L Knockout cell line (HEK293) | Human | INTS6L | 1:3~1:6 | Negative | Online Inquiry |
INTS6L Gene Knockout Cell Lines are specialized cellular models engineered to specifically lack the integrator complex subunit 6-like (INTS6L) gene, a component implicated in various biological processes including mRNA maturation and regulation of gene expression. These cell lines serve as crucial tools for researchers aiming to elucidate the functional role of INTS6L in cellular pathways, particularly under conditions that mimic disease states or developmental processes.
The primary mechanism behind these knockout cell lines involves the targeted deletion of the INTS6L gene using CRISPR-Cas9 technology, allowing for precise genomic modifications. Researchers can utilize these cell lines to investigate how the absence of INTS6L affects cellular functions such as proliferation, apoptosis, and response to stress. This mechanism enables an in-depth exploration of the gene’s role in pathophysiological contexts, providing insights into its involvement in cancer, neurodegenerative diseases, and other disorders.
The scientific importance of INTS6L Gene Knockout Cell Lines cannot be overstated; they offer a controlled system for understanding complex gene functions, and their applications extend to developmental biology, pharmacology, and genetic research. In clinical settings, these models can accelerate the creation of therapeutic strategies by providing early insights into gene interactions and potential drug targets.
What sets our INTS6L Gene Knockout Cell Lines apart is their unparalleled accuracy in gene modification, coupled with robust validation data that provides researchers confidence in their findings. Unlike competitor products that may offer non-specific or poorly characterized knockout models, our cell lines guarantee high fidelity in gene disruption, enabling reproducible and reliable experimental results.
Ultimately, the value of INTS6L Gene Knockout Cell Lines lies in their potential to advance our understanding of gene function and interaction, making them indispensable resources for researchers and clinicians alike. Our company specializes in the development of advanced genetic models and has a proven track record of delivering high-quality biological products, ensuring that our customers have access to the tools needed to make significant scientific breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.